“Glucose, Urea, and Creatinine Laboratory Tests in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil”. Research, Society and Development, vol. 11, no. 5, Apr. 2022, p. e43711528541, https://doi.org/10.33448/rsd-v11i5.28541.